RHBC
PGEN icon

R.H. Bluestein & Co’s Precigen PGEN Stock Holding History

R.H. Bluestein & Co’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,045
Closed -$244K – 318
2015
Q2 		$244K Sell
5,045
-187
-4% -$7.88K 0.01% 296
2015
Q1 		$227K Buy
+5,232
New +$188K 0.01% 306

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

R.H. Bluestein & Co's PGEN Position: Q3 2015 in Review

R.H. Bluestein & Co sold out of Precigen (PGEN) in Q3 2015, closing a stake of 5,045 shares — an estimated $244K sold.

R.H. Bluestein & Co first reported a position in PGEN in Q1 2015 and held it in 2 quarters. The position peaked at $244K in Q2 2015. 173 funds tracked by Wall St. Rank hold PGEN as of Q3 2015.

  • R.H. Bluestein & Co reported no remaining Precigen position as of Q3 2015 after selling out during the quarter.
  • R.H. Bluestein & Co sold 5,045 Precigen shares in Q3 2015, an estimated $244K.
  • R.H. Bluestein & Co first reported a position in Precigen in Q1 2015 and held it in 2 quarters.
  • R.H. Bluestein & Co's Precigen position peaked at $244K in Q2 2015.
  • 173 funds tracked by Wall St. Rank held Precigen as of Q3 2015.

Based on R.H. Bluestein & Co's 13F filing for Q3 2015, filed 13 Nov 2015.